Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy

Rituximab is an anti-CD20 monoclonal antibody frequently used for the treatment of non-Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), and anti-neutrophilic cytoplasmic antibody (ANCA)-associated vasculitis. In addition, rituximab has recently been increasingly use...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheungpasitporn, Wisit, Kopecky, Stephen L., Specks, Ulrich, Bharucha, Kharmen, Fervenza, Fernando C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nickan Research Institute 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414514/
https://www.ncbi.nlm.nih.gov/pubmed/28487867
http://dx.doi.org/10.15171/jrip.2017.04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414514/
https://www.ncbi.nlm.nih.gov/pubmed/28487867
http://dx.doi.org/10.15171/jrip.2017.04

Ejemplares similares